Sign Up to like & get recommendations! 0
Published in 2019 at "Clinical Cardiology"
DOI: 10.1002/clc.23245
Abstract: Despite the technical improvements made in recent years, the overall longāterm success rate of ventricular tachycardia (VT) ablation in patients with ischemic cardiomyopathy remains disappointing. This unsatisfactory situation has persisted even though several approaches to… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Clinical Cardiology"
DOI: 10.1002/clc.23779
Abstract: In clinical practice, we encounter ischemic cardiomyopathy (ICM) with underlying viable, dysfunctional myocardium on a regular basis. Evidence from the Surgical Treatment for Ischemic Heart failure (STICH) and its Extension Study is supportive of improved… read more here.
Sign Up to like & get recommendations! 1
Published in 2022 at "Heart and Vessels"
DOI: 10.1007/s00380-021-01990-0
Abstract: Recurrence of left ventricular (LV) remodeling after surgical ventricular reconstruction (SVR) for ischemic cardiomyopathy has been reported to be partially attributed to autophagy. We aimed to examine the effects of trehalose, an autophagy inducer, on… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Basic Research in Cardiology"
DOI: 10.1007/s00395-018-0710-1
Abstract: Preclinical investigations support the concept that donor cells more oriented towards a cardiovascular phenotype favor repair. In light of this philosophy, we previously identified HDAC1 as a mediator of cardiac mesenchymal cell (CMC) cardiomyogenic lineage… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Journal of Interventional Cardiac Electrophysiology"
DOI: 10.1007/s10840-018-0376-5
Abstract: BackgroundCatheter ablation is proven to be an effective strategy for drug refractory ventricular tachycardia (VT) in ischemic cardiomyopathy. However, the appropriate timing of VT ablation and identifying the group of patients that may receive the… read more here.
Sign Up to like & get recommendations! 0
Published in 2017 at "General Thoracic and Cardiovascular Surgery"
DOI: 10.1007/s11748-017-0773-1
Abstract: ObjectivesThe impact of surgical ventricular restoration (SVR) on survival and major adverse cardiac events (MACEs) is still controversial. The purposes of this study were to analyze our surgical experience with SVR for ischemic cardiomyopathy and… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "General Thoracic and Cardiovascular Surgery"
DOI: 10.1007/s11748-019-01123-5
Abstract: ObjectivesTo analyze our surgical experiences with surgical ventricular restoration (SVR) for dilated ischemic cardiomyopathy (ICM) and to determine the significance of preoperative right ventricular (RV) function on outcomes.Methods and resultsThis study retrospectively analyzed 19 patients… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "General Thoracic and Cardiovascular Surgery"
DOI: 10.1007/s11748-019-01187-3
Abstract: Objective Although surgical ventricular restoration for ischemic cardiomyopathy is expected as an alternative or bridge to heart transplantation, post-operative remodeling of left ventricle (LV) needs to be addressed. This study aimed to examine the effect… read more here.
Sign Up to like & get recommendations! 1
Published in 2018 at "Current Cardiology Reports"
DOI: 10.1007/s11886-018-0974-y
Abstract: Purpose of ReviewRecent evidence has suggested that implantable defibrillator (ICD) in non-ischemic cardiomyopathy (NICM) may not offer mortality benefit in the presence of guideline-directed medical therapy (GDMT) and cardiac resynchronization therapy (CRT).Recent FindingsDespite significant benefits… read more here.
Sign Up to like & get recommendations! 0
Published in 2018 at "Current Cardiology Reports"
DOI: 10.1007/s11886-018-1066-8
Abstract: Purpose of ReviewThe purpose of this review is to examine current evidence on the benefit of chronic total occlusion (CTO) revascularization in patients with ischemic cardiomyopathy and propose a systematic approach on how and when… read more here.
Sign Up to like & get recommendations! 0
Published in 2019 at "Journal of Nuclear Cardiology"
DOI: 10.1007/s12350-019-01684-1
Abstract: Objective Positron emission tomography (PET) integrating assessment of perfusion with 13 N-ammonia (NH3) and viability with 18 F-fluorodeoxyglucose (FDG) has high accuracy to identify viable, hibernating myocardium. We tested whether quantification of myocardial blood flow… read more here.